Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 288

As the world’s population continues to grow and age, the healthcare system in different geographies is inching closer to the brink of collapse. According to the World Health Organization, the current number of health workers, including physicians, radiologists, and other professionals, is not sufficient to handle the rising caseload. On top of it, the increased stress and burnout stemming from the surge in cases is pushing many to exit the field, further reducing the number of practicing workers. Becker Health estimates show that nearly 72,000 American physicians left the workforce between 2021 and 2022, and some 30,000 who will join the workforce will not be enough to meet the growing demand.

At the core, both these challenges – the rising caseload and dwindling workforce – are leaving one major impact: diminished quality of patient care. This is where the much talked about generative AI can come in, saving healthcare staffers valuable time and resources and enabling them to focus on enhancing clinical outcomes.

First off, it’s important to understand AI is not new in healthcare. Organizations have been experimenting with predictive and computer vision algorithms for a while now, most notably to forecast the success of treatments and diagnose dangerous diseases earlier than humans. However, when it comes to generative AI, things are still pretty fresh, given the technology came to the forefront just a couple of years ago with the launch of ChatGPT. Gen AI models use neural networks to identify patterns and structures in existing data and generate new content such as text and images. They are applicable across sectors, including healthcare – where organizations cumulatively generate about 300 petabytes of data every single day.

Read more | >

I love the first line.

In this video I spoke with Rupert Sheldrake about the science experiments that will change the world, taking us from morphic resonance, telepathy to aging research.

Find out about Rupert here:

Continue reading “Science Experiments That Will Change The World — Rupert Sheldrake, PhD” | >

Researchers at Rensselaer Polytechnic Institute have fabricated a device no wider than a human hair that will help physicists investigate the fundamental nature of matter and light. Their findings, published in the journal Nature Nanotechnology (“Topological valley Hall polariton condensation”), could also support the development of more efficient lasers, which are used in fields ranging from medicine to manufacturing.

The device is made of a special kind of material called a photonic topological insulator. A photonic topological insulator can guide photons, the wave-like particles that make up light, to interfaces specifically designed within the material while also preventing these particles from scattering through the material itself.

Because of this property, topological insulators can make many photons coherently act like one photon. The devices can also be used as topological “quantum simulators,” miniature laboratories where researchers can study quantum phenomenon, the physical laws that govern matter at very small scales.

Read more | >

Keeping people healthy in space and developing novel therapies with space technologies — dr. masayuki goto, MD, phd — director, space medical accelerator.

Dr. Masayuki Goto, MD, PhD is Director and President of the Space Medical Accelerator (https://space-healthcare.jp/), an organization founded in 2022 in Japan with a mission to keep people healthy in space and to develop terrestrial medicine by utilizing space technology and research.

Dr. Goto is a Medical Doctor, a Neurosurgeon, and a Space Medicine researcher with degrees from University of Tsukuba and Yamagata University.

Continue reading “Dr. Masayuki Goto, MD, PhD — Director, Space Medical Accelerator — Keeping People Healthy In Space” | >

Championing an aerospace renaissance — elizabeth reynolds, managing director, US, starburst aerospace.

Elizabeth Reynolds is Managing Director, US of Starburst Aerospace (https://starburst.aero/), a global Aerospace and Defense (A\&D) startup accelerator and strategic advisory practice championing today’s aerospace renaissance, aligning early-stage technology innovators with government and commercial stakeholders and investors to modernize infrastructure in space, transportation, communications, and intelligence.

Elizabeth’s team works alongside hundreds of technology startups developing new aircraft, spacecraft, satellites, drones, sensors, autonomy, robotics, and much more.

Continue reading “Elizabeth Reynolds, Managing Director, US, Starburst Aerospace; Championing An Aerospace Renaissance” | >

Episode Disclaimer — The views presented in this episode are those of the speaker and do not necessarily represent the views of the United States Department of Defense (DoD) or its components.

Dr. Diane DiEuliis, Ph.D. is a Distinguished Research Fellow at National Defense University (NDU — https://www.ndu.edu/), an institution of higher education, funded by the United States Department of Defense, aimed at facilitating high-level education, training, and professional development of national security leaders. Her research areas focus on emerging biological technologies, biodefense, and preparedness for biothreats. Specific topic areas under this broad research portfolio include dual-use life sciences research, synthetic biology, the U.S. bioeconomy, disaster recovery, and behavioral, cognitive, and social science as it relates to important aspects of deterrence. Dr. DiEuliis currently has several research grants in progress, and teaches in foundational professional military education.

Prior to joining NDU, Dr. DiEuliis was Deputy Director for Policy, and served as Deputy Assistant Secretary for Policy and Planning in the Office of the Assistant Secretary for Preparedness and Response (ASPR), Department of Health and Human Services. She coordinated policy and research in support of domestic and international health emergencies, such as Hurricane Sandy, and Ebola outbreaks. She was responsible for implementation of the Pandemic All-Hazards Preparedness Act, the National Health Security Strategy, and supported the Public Health Emergency Medical Countermeasures Enterprise (PHEMCE).

From to 2007 to 2011, Dr. DiEuliis was the Assistant Director for Life Sciences and Behavioral and Social Sciences in the Office of Science and Technology Policy (OSTP) in the Executive Office of the President. During her tenure at the White House, she was responsible for developing policy in areas such as biosecurity and biodefense, synthetic biology, social and behavioral science, scientific collections, and biotechnology. Dr. DiEuliis also worked to help coordinate agency response to public health issues such as the H1N1 flu.

Continue reading “Dr. Diane DiEuliis — NDU — Preparing National Security Leaders For The Next Generation Of Threats” | >

Reid was part of a 60-participant clinical trial that looked to use spinal cord stimulation to regain control of both hands. Similar treatments have shown promise in paraplegic patients, restoring the ability to walk in just a day. But those required surgery to place electrodes on the spinal cord.

ARC-EX therapy, by contrast, delivers two different types of electrical pulses through the skin—no surgery required. Developed by Grégoire Courtine and colleagues at the Swiss Federal Institute of Technology, the device improved hand strength, pinch, and other movements in 72 percent of participants.

Because the device is non-invasive, it’s a simple addition to physical rehabilitation programs—a sort of pilates for the fingers, explained the team. The trial only included two months of stimulation, and extending the timeline could potentially further improve results.

Read more | >